Abstract:Objectives Lipoprotein-Associated Phospholipase A2 (Lp-PLA2), an enzyme produced by inflammatory cells, is an emerging risk factor and a potential therapeutic target. Findings from previous studies investigating the association between PLA2G7 gene (encode Lp-PLA2 protein) polymorphisms and Lp-PLA2 activity are inconsistent. Hence, a meta-analysis with multiethnic populations was conducted to evaluate the association between four well-characterised PLA2G7 gene polymorphisms (A379V, V279F, I198T and R92H) and Lp-PLA2 activity. Methods MEDLINE, EMBASE, CNKI (Chinese National Knowledge Infrastructure) and Wanfang databases (prior to January 2013) were searched for case-control, nested case-control, or cross-sectional studies on the association between PLA2G7 polymorphisms and Lp-PLA2 activity. Duplicate publications, studies without interested loci, or Genome-Wide Association (GWA) studies were excluded. Data from an unpublished study with a total of 1268 subjects were included as well. Standardised mean difference (SMD) and its corresponding 95% confidence interval (CI) were calculated to assess the association between PLA2G7 polymorphisms and Lp-PLA2 activity. A panel of subgroup analyses was also conducted. Results A total of 11 articles involving 4 polymorphisms in PLA2G7 gene were included (A379V (6 articles), V279F (6 articles), I198T (5 articles) and R92H (5 articles)). A379V was significantly associated with an elevated Lp-PLA2 activity, yielding a pooled SMD of 0.15 (0.06, 0.24) for comparison of AV vs. AA, 0.30(0.18, 0.42) for comparison of VV vs. AA, 0.06(0.01, 0.12) under dominant model and 0.19(0.08, 0.30) under recessive model. Subgroup analysis showed a significant ethnic difference, with the impact of A379V was only found in Caucasians. V279F was only found in Asians and significantly associated with a decreased Lp-PLA2 activity, yielding SMD of -1.54(-1.84,-1.24) for comparison of VF vs. VV, -2.92(-3.37,-2.48) for comparison of FF vs. VV, -1.52(-1.57, -1.46) under dominant model and -2.96(-3.10, -2.82) under recessive model. R92H was associated with Lp-PLA2 activity for comparison of RH vs. RR (SMD = -0.11, 95%CI: -0.16 to -0.05, P < 0.001) and dominant model (SMD = -0.11, 95%CI: -0.16 to -0.06, P < 0.001), with the significant impact only found in Caucasians by subgroup analysis. The overall impact of I198T polymorphism was not significantly associated with Lp-PLA2 activity. However, in Asians, I198T was found to be associated with Lp-PLA2 activity for comparison of IT vs. II (SMD = -0.53, 95%CI: -0.68 to -0.37, P < 0.001) and dominant model (SMD = -0.53, 95%CI: -0.68 to -0.38, P < 0.001). Conclusions This meta-analysis found that A379V, V279F, and R92H were associated with Lp-PLA2 activity, with a remarkable ethnic difference existing. Our findings may provide important information for the identification of high-risk individuals of cardiovascular disease and target population for the potential intervention with Lp-PLA2 inhibitor.

GW24-e1876 PLA2G7 Gene Polymorphisms and Lipoprotein-Associated Phospholipase A2 Activity: a Meta-Analysis

A Phenome-Wide Association Study of A Lipoprotein-Associated Phospholipase A(2) Loss-Of-Function Variant in 90 000 Chinese Adults

A Previously Unreported Impact of a PLA2G7 Gene Polymorphism on the Plasma Levels of Lipoprotein-Associated Phospholipase A2 Activity and Mass

Associations between four types of single-nucleotide polymorphisms in PLA2G7 gene and clinical atherosclerosis: a meta-analysis.

Associations Between LPL Gene Polymorphisms and Coronary Artery Disease: Evidence Based on an Updated and Cumulative Meta-Analysis.

Associations of I198T Gene Polymorphisms with Plasma Lipoprotein-Associated Phospholipase A2 Activity and Coronary Heart Disease

Association of lipoprotein-associated phospholipase A2 gene polymorphism with prognosis of coronary heart disease

Associations of PNPLA3 Rs738409 Polymorphism with Plasma Lipid Levels: A Systematic Review and Meta-Analysis

Correlation among polymorphisms of Lp-PLA2, susceptibility and clinical characteristics in patients with acute myocardial infarction

Analysis on the Association Between PPARα/γ Polymorphisms and Lipoprotein(a) in a Chinese Han Population.

Association between PLA2R gene polymorphism and idiopathic membranous nephropathy in Heilongjiang Chinese

GW24-e0047 Gender Difference in Lipoprotein-Associated Phospholipase A2 Activity and Its Association with Cardiovascular Risk Factors

Association Between Lipoprotein-Associated Phospholipase A2 Gene R92H Polymorphism and Coronary Heart Disease in Han Chinese

Association between activity and I198T of lipoprotein-associated phospholipase A2 and Type 2 Diabetes Mellitus

Patatin-like Phospholipase Domain-Containing 3 Gene (PNPLA3) Polymorphic (rs738409) Single Nucleotide Polymorphisms and Susceptibility to Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Twenty Studies

Lack of Association Between PLA2G6 Genetic Variation and Parkinson's Disease: A Systematic Review.

Genetic Invalidation of Lp-PLA2 As a Therapeutic Target: Large-scale Study of Five Functional Lp-PLA2-lowering Alleles

Haplotype Analysis of Peroxisome Proliferator-activated Receptor Γ Gene Polymorphisms and the Lipoprotein (a) Level

Lipoprotein-Associated Phospholipase A(2) And Risk Of Coronary Disease, Stroke, And Mortality: Collaborative Analysis Of 32 Prospective Studies

Lipoprotein-Associated Phospholipase A2 in Coronary Heart Disease: Review and Meta-Analysis

The HindIII and PvuII polymorphisms of lipoprotein lipase (LPL) gene reduce the risk of ischemic stroke (IS): A meta-analysis.